Nicholas Investment Partners, LP Oric Pharmaceuticals, Inc. Transaction History
Nicholas Investment Partners, LP
- $910 Million
- Q2 2025
A detailed history of Nicholas Investment Partners, LP transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 74,242 shares of ORIC stock, worth $940,646. This represents 0.08% of its overall portfolio holdings.
Number of Shares
74,242
Previous 154,379
51.91%
Holding current value
$940,646
Previous $861,000
12.54%
% of portfolio
0.08%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding ORIC
# of Institutions
146Shares Held
91.9MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$90.8 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$83.6 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$83.3 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$67 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$61.2 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $501M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...